SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,249.39 -460.30
( -0.62%)

Global Indices

Nasdaq

52,880.09 363.21
(0.69%)

Dow Jones

7,780.08 46.51
(0.60%)

Hang Seng

63,134.14 -1,487.10
(-2.30%)

Nikkei 225

10,751.68 18.68
(0.17%)

Forex

USD-INR

94.82 -0.08
(-0.09%)

EUR-INR

106.45 0.01
(0.01%)

GBP-INR

126.63 0.25
(0.20%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Consolidated Finvest & Holdings Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

500226

INE025A01027

358.2396349

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONSOFINVT

16.72

910.41

EPS(TTM)

Face Value()

Div & Yield %

16.82

0.52

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

Aug 03,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	938.44	805.17	17
OPM %	31.49	31.20	-
PBDT	338.29	294.50	15
PBT	322.45	278.98	16
NP	237.18	205.01	16

73,249.39 -460.30 ( -0.62%)

52,880.09 363.21 (0.69%)

7,780.08 46.51 (0.60%)

63,134.14 -1,487.10 (-2.30%)

10,751.68 18.68 (0.17%)

94.82 -0.08 (-0.09%)

106.45 0.01 (0.01%)

126.63 0.25 (0.20%)

0.60 0.00 (-0.04%)